A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Public ClinicalTrials.gov record NCT07391657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Open-label, Randomised, Multicentre Study Comparing AZD0120, a Dual-Targeting Autologous Chimeric Antigen Receptor T-cell (CART) Therapy Directed Against BCMA and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma.
Study identification
- NCT ID
- NCT07391657
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 508 participants
Conditions and interventions
Conditions
Interventions
- AZD0120 Biological
- Bortezomib Drug
- Carfilzomib Drug
- Daratumumab Drug
- Dexamethasone Drug
- Pomalidomide Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 22, 2026
- Primary completion
- Jun 13, 2028
- Completion
- Aug 11, 2030
- Last update posted
- Apr 29, 2026
2026 – 2030
United States locations
- U.S. sites
- 43
- U.S. states
- 25
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Gilbert | Arizona | 85234 | Not yet recruiting |
| Research Site | Phoenix | Arizona | 85054 | Not yet recruiting |
| Research Site | Tucson | Arizona | 85719 | Not yet recruiting |
| Research Site | La Jolla | California | 92093 | Withdrawn |
| Research Site | Sacramento | California | 95817 | Not yet recruiting |
| Research Site | Santa Monica | California | 90404 | Not yet recruiting |
| Research Site | Denver | Colorado | 80218 | Not yet recruiting |
| Research Site | New Haven | Connecticut | 06510 | Not yet recruiting |
| Research Site | Washington D.C. | District of Columbia | 20007 | Not yet recruiting |
| Research Site | Coral Gables | Florida | 33156 | Not yet recruiting |
| Research Site | Atlanta | Georgia | 30322 | Not yet recruiting |
| Research Site | Chicago | Illinois | 60612 | Not yet recruiting |
| Research Site | Park Ridge | Illinois | 60068 | Withdrawn |
| Research Site | Iowa City | Iowa | 52242 | Withdrawn |
| Research Site | Kansas City | Kansas | 66160 | Not yet recruiting |
| Research Site | Louisville | Kentucky | 40207 | Not yet recruiting |
| Research Site | Boston | Massachusetts | 02114 | Not yet recruiting |
| Research Site | Boston | Massachusetts | 02215 | Withdrawn |
| Research Site | Detroit | Michigan | 48201 | Withdrawn |
| Research Site | Detroit | Michigan | 48202 | Withdrawn |
| Research Site | Rochester | Minnesota | 55905 | Not yet recruiting |
| Research Site | New York | New York | 10016 | Withdrawn |
| Research Site | New York | New York | 10029 | Not yet recruiting |
| Research Site | New York | New York | 10065 | Not yet recruiting |
| Research Site | Rochester | New York | 14642 | Withdrawn |
| Research Site | The Bronx | New York | 10467 | Withdrawn |
| Research Site | Chapel Hill | North Carolina | 27514 | Not yet recruiting |
| Research Site | Charlotte | North Carolina | 28204 | Not yet recruiting |
| Research Site | Winston-Salem | North Carolina | 27103 | Not yet recruiting |
| Research Site | Cincinnati | Ohio | 45220 | Not yet recruiting |
| Research Site | Cleveland | Ohio | 44195 | Not yet recruiting |
| Research Site | Portland | Oregon | 97239 | Not yet recruiting |
| Research Site | Charleston | South Carolina | 29425 | Withdrawn |
| Research Site | Nashville | Tennessee | 37203 | Not yet recruiting |
| Research Site | Austin | Texas | 78704 | Not yet recruiting |
| Research Site | Dallas | Texas | 75235 | Not yet recruiting |
| Research Site | Houston | Texas | 77030 | Not yet recruiting |
| Research Site | Salt Lake City | Utah | 84112 | Not yet recruiting |
| Research Site | Charlottesville | Virginia | 22908 | Withdrawn |
| Research Site | Richmond | Virginia | 23298 | Withdrawn |
| Research Site | Seattle | Washington | 98104 | Not yet recruiting |
| Research Site | Madison | Wisconsin | 53792 | Not yet recruiting |
| Research Site | Milwaukee | Wisconsin | 53226 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07391657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07391657 live on ClinicalTrials.gov.